(July 2009)
ISSN 0007-0920
Welcome to BJC
Multidisciplinary Journal of Cancer Research
BJC publishes high quality original papers and reviews that make a significant contribution to increasing understanding of the causes of cancer and to improving the treatment and survival of patients.
BJC is proud of its editorial independence, high standards, and tradition of serving the international cancer research community - we are one of the world's leading general cancer journals.
NEW Impact factor 4.846
2008 Journal Citation Reports (Thomson Reuters, 2009)
Trends and inequalities in survival for 20 cancers in England and Wales 1986-2001: population-based analyses and clinical commentaries
This Cancer Research UK supplement provides important new information and commentary on survival rates for the 20 most common cancers diagnosed in England and Wales over a 14-year period from 1986 to 1999. The analyses are based on data collected by cancer registries on 2.2 million cancer patients. The authors have assessed both trends in survival rates over time and inequalities in survival between groups of patients with different levels of deprivation. The unique pairing of epidemiology and expert clinical analysis should provide a complete picture of the state of cancer survival and cancer care in England and Wales.
Click here to view the supplement.
Archive
Coinciding with the release of the first issue of Volume 99 of BJC on 1st July 2008, and the launch of our new website design, BJC, NPG and Cancer Research UK are pleased to announce that all BJC papers will become freely available to readers of this website, 12 months after they are published.
This applies in the first instance to papers published in and after 1999. Please see our Archive page for the details.
Featured Articles
-
Early diagnosis of oesophageal cancer FREE
-
Prognosis and predictive value of KIT exon 11 deletion in GISTs FREE
-
High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series FREE
-
Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells FREE
-
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy FREE
-
The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas FREE
-
Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial FREE
-
Cancer incidence in British vegetarians FREE
-
Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?
-
Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
-
Migration rules: tumours are conglomerates of self-metastases
-
Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation
-
Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer
-

